Sodium fluorescein is a probe substrate for hepatic drug transport mediated by OATP1B1 and OATP1B3

Journal of Pharmaceutical Sciences

Volumn 100, Issue 11, 2011, Pages 5018-5030

  De Bruyn, Tom ^a   Fattah, Sarinj ^a   Stieger, Bruno ^b   Augustijns, Patrick ^a   Annaert, Pieter ^a  

^a DEPARTMENT OF PHARMACEUTICAL AND PHARMACOLOGICAL SCIENCES   (Belgium)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Drug interactions; Hepatic transport; Hepatocytes; Organic anion transporting polypeptide; pharmacokinetics

Indexed keywords

AMPRENAVIR; ATAZANAVIR; BILE SALT; DARUNAVIR; FLUORESCEIN SODIUM; NELFINAVIR; ORGANIC ANION TRANSPORTER 1; RITONAVIR; SAQUINAVIR;

ANIMAL CELL; ARTICLE; DRUG LABELING; EXTRACELLULAR FLUID; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL; LIVER METABOLISM; MALE; NONHUMAN; OVARY CELL; RAT; SODIUM TRANSPORT; TRANSPORT KINETICS;

EID: 80053241509     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22694     Document Type: Article

References (46)

1. Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, Chu X, Dahlin A, Evers R, Fischer V, Hillgren KM, Hoffmaster KA, Ishikawa T, Keppler D, Kim RB, Lee CA, Niemi M, Polli JW, Sugiyama Y, Swaan PW, Ware JA, Wright SH, Yee SW, Zamek-Gliszczynski MJ, Zhang L. 2010. Membrane transporters in drug development. Nat Rev Drug Discov 9:215-236.
2. Hagenbuch B, Gui C. 2008. Xenobiotic transporters of the human organic anion transporting polypeptides (OATP) family. Xenobiotica 38:778-801.
3. Stieger B. 2011. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation. Handb Exp Pharmacol 201:205-259.
4. Ho RH, Tirona RG, Leake BF, Glaeser H, Lee W, Lemke CJ, Wang Y, Kim RB. 2006. Drug and bile acid transporters in rosuvastatin hepatic uptake: Function, expression, and pharmacogenetics. Gastroenterology 130:1793-1806.
5. Yanni SB, Augustijns PF, Benjamin DKJ, Brouwer KL, Thakker DR, Annaert PP. 2010. in vitro investigation of the hepatobiliary disposition mechanisms of the antifungal agent micafungin in humans and rats. Drug Metab Dispos 38:1848-1856.
6. Annaert P, Swift B, Lee JK, Brouwer KLR. 2007. Drug transport in the liver. In Drug transporters: Molecular characterization and role in drug disposition; You G, Morris M, Eds. Hoboken, New Jersey: John Wiley & Sons, Inc., pp 359-410.
7. Parker AJ, Houston JB. 2008. Rate-limiting steps in hepatic drug clearance: Comparison of hepatocellular uptake and metabolism with microsomal metabolism of saquinavir, nelfinavir, and ritonavir. Drug Metab Dispos 36:1375-1384.
8. Yamazaki M, Akiyama S, Nishigaki R, Sugiyama Y. 1996. Uptake is the rate-limiting step in the overall hepatic elimination of pravastatin at steady-state in rats. Pharm Res 13:1559-1564.
9. Kindla J, Fromm MF, Konig J. 2009. in vitro evidence for the role of OATP and OCT uptake transporters in drug-drug interactions. Expert Opin Drug Metab Toxicol 5:489-500.
10. Neuvonen PJ. 2010. Drug interactions with HMG-CoA reductase inhibitors (statins): The importance of CYP enzymes, transporters and pharmacogenetics. Curr Opin Investig Drugs 11:323-332.
11. Treiber A, Schneiter R, Hausler S, Stieger B. 2007. Bosentan is a substrate of human OATP1B1 and OATP1B3: Inhibition of hepatic uptake as the common mechanism of its interactions with cyclosporin A, rifampicin, and sildenafil. Drug Metab Dispos 35:1400-1407.
12. Annaert PP, Brouwer KL. 2005. Assessment of drug interactions in hepatobiliary transport using rhodamine 123 in sandwich-cultured rat hepatocytes. Drug Metab Dispos 33:388-394.
13. Crespi CL, Stresser DM. 2000. Fluorometric screening for metabolism-based drug-drug interactions. J Pharmacol Toxicol Methods 44:325-331.
14. Ye ZW, Van Pelt J, Camus S, Snoeys J, Augustijns P, Annaert P. 2010. Species-specific interaction of HIV protease inhibitors with accumulation of cholyl-glycylamido-fluorescein (CGamF) in sandwich-cultured hepatocytes. J Pharm Sci 99:2886-2898.
15. Zamek-Gliszczynski MJ, Xiong H, Patel NJ, Turncliff RZ, Pollack GM, Brouwer KL. 2003. Pharmacokinetics of 5 (and 6)-carboxy-2', 7'-dichlorofluorescein and its diacetate promoiety in the liver. J Pharmacol Exp Ther 304:801-809.
16. Baldes C, Koenig P, Neumann D, Lenhof HP, Kohlbacher O, Lehr CM. 2006. Development of a fluorescence-based assay for screening of modulators of human organic anion transporter 1B3 (OATP1B3). Eur J Pharm Biopharm 62:39-43.
17. Bednarczyk D. 2010. Fluorescence-based assays for the assessment of drug interaction with the human transporters OATP1B1 and OATP1B3. Anal Biochem 405:50-58.
18. Gui C, Obaidat A, Chaguturu R, Hagenbuch B. 2010. Development of a cell-based high-throughput assay to screen for inhibitors of organic anion transporting polypeptides 1B1 and 1B3. Curr Chem Genomics 4:1-8.
19. Yamaguchi H, Okada M, Akitaya S, Ohara H, Mikkaichi T, Ishikawa H, Sato M, Matsuura M, Saga T, Unno M, Abe T, Mano N, Hishinuma T, Goto J. 2006. Transport of fluorescent chenodeoxycholic acid via the human organic anion transporters OATP1B1 and OATP1B3. J Lipid Res 47:1196-1202.
20. Yamaguchi K, Murai T, Yabuuchi H, Hui SP, Kurosawa T. 2010. Measurement of bile salt export pump transport activities using a fluorescent bile acid derivative. Drug Metab Pharmacokinet 25:214-219.
21. Ye ZW, Augustijns P, Annaert P. 2008. Cellular accumulation of cholyl-glycylamido-fluorescein in sandwich-cultured rat hepatocytes: Kinetic characterization, transport mechanisms, and effect of human immunodeficiency virus protease inhibitors. Drug Metab Dispos 36:1315-1321.
22. de Waart DR, Hausler S, Vlaming ML, Kunne C, Hanggi E, Gruss HJ, Oude Elferink RP, Stieger B. 2010. Hepatic transport mechanisms of cholyl-L-lysyl-fluorescein. J Pharmacol Exp Ther 334:78-86.
23. Gebhardt R, Jung W. 1982. Biliary secretion of sodium fluorescein in primary monolayer cultures of adult rat hepatocytes and its stimulation by nicotinamide. J Cell Sci 56:233-244.
24. Mills CO, Milkiewicz P, Muller M, Roma MG, Havinga R, Coleman R, Kuipers F, Jansen PL, Elias E. 1999. Different pathways of canalicular secretion of sulfated and non-sulfated fluorescent bile acids: A study in isolated hepatocyte couplets and TR- rats. J Hepatol 31:678-684.
25. Stone RA, Wilson CM. 1982. Fluorescein transport in the anterior uvea. Invest Ophthalmol Vis Sci 22:303-309.
26. Badolo L, Rasmussen LM, Hansen HR, Sveigaard C. 2010. Screening of OATP1B1/3 and OCT1 inhibitors in cryopreserved hepatocytes in suspension. Eur J Pharm Sci 40:282-288.
27. Lau YY, Sapidou E, Cui X, White RE, Cheng KC. 2002. Development of a novel in vitro model to predict hepatic clearance using fresh, cryopreserved, and sandwich-cultured hepatocytes. Drug Metab Dispos 30:1446-1454.
28. Griffin SJ, Houston JB. 2005. Prediction of in vitro intrinsic clearance from hepatocytes: Comparison of suspensions and monolayer cultures. Drug Metab Dispos 33:115-120.
29. Shitara Y, Li AP, Kato Y, Lu C, Ito K, Itoh T, Sugiyama Y. 2003. Function of uptake transporters for taurocholate and estradiol 17beta-d-glucuronide in cryopreserved human hepatocytes. Drug Metab Pharmacokinet 18:33-41.
30. De Bruyn T, Ye Z, Sahi J, Augustijns P, Annaert P. Determination of OATP-, NTCP- and OCT-mediated substrate uptake activities in individual and pooled batches of cryopreserved human hepatocytes. Eur J Pharm Sci (In press).
31. Annaert PP, Turncliff RZ, Booth CL, Thakker DR, Brouwer KL. 2001. P-glycoprotein-mediated in vitro biliary excretion in sandwich-cultured rat hepatocytes. Drug Metab Dispos 29:1277-1283.
32. Schroeder A, Eckhardt U, Stieger B, Tynes R, Schteingart CD, Hofmann AF, Meier PJ, Hagenbuch B. 1998. Substrate specificity of the rat liver Na(+)-bile salt cotransporter in Xenopus laevis oocytes and in CHO cells. Am J Physiol 274:G370-G375.
33. Kakkar T, Boxenbaum H, Mayersohn M. 1999. Estimation of Ki in a competitive enzyme-inhibition model: Comparisons among three methods of data analysis. Drug Metab Dispos 27:756-762.
34. Annaert P, Ye ZW, Stieger B, Augustijns P. 2010. Interaction of HIV protease inhibitors with OATP1B1, 1B3, and 2B1. Xenobiotica 40:163-176.
35. Sandker GW, Weert B, Olinga P, Wolters H, Slooff MJH, Meijer DKF, Groothuis GMM. 1994. Characterization of transport in isolated human hepatocytes: A study with the bile acid taurocholic acid, the uncharged ouabain and the organic cations vecuronium and rocuronium. Biochem Pharmacol 47:2193-2200.
36. Leuthold S, Hagenbuch B, Mohebbi N, Wagner CA, Meier PJ, Stieger B. 2009. Mechanisms of pH-gradient driven transport mediated by organic anion polypeptide transporters. Am J Physiol Cell Physiol 296:C570-82.
37. Nozawa T, Imai K, Nezu J, Tsuji A, Tamai I. 2004. Functional characterization of pH-sensitive organic anion transporting polypeptide OATP-B in human. J Pharmacol Exp Ther 308:438-445.
38. Marin JJ, Mangas D, Martinez-Diez MC, El-Mir MY, Briz O, Serrano MA. 2003. Sensitivity of bile acid transport by organic anion-transporting polypeptides to intracellular pH. Biochim Biophys Acta. 1611:249-257.
39. Gorboulev V, Shatskaya N, Volk C, Koepsell H. 2005. Subtype-specific affinity for corticosterone of rat organic cation transporters rOCT1 and rOCT2 depends on three amino acids within the substrate binding region. Mol Pharmacol 67:1612-1619.
40. Koepsell H, Lips K, Volk C. 2007. Polyspecific organic cation transporters: Structure, function, physiological roles, and biopharmaceutical implications. Pharm Res 24:1227-1251.
41. Sekine T, Cha SH, Tsuda M, Apiwattanakul N, Nakajima N, Kanai Y, Endou H. 1998. Identification of multispecific organic anion transporter 2 expressed predominantly in the liver. FEBS Lett 429:179-182.
42. Morita N, Kusuhara H, Nozaki Y, Endou H, Sugiyama Y. 2005. Functional involvement of rat organic anion transporter 2 (Slc22a7) in the hepatic uptake of the nonsteroidal anti-inflammatory drug ketoprofen. Drug Metab Dispos 33:1151-1157.
43. Shitara Y, Sugiyama D, Kusuhara H, Kato Y, Abe T, Meier PJ, Itoh T, Sugiyama Y. 2002. Comparative inhibitory effects of different compounds on rat oatpl (slc21a1)- and Oatp2 (Slc21a5)-mediated transport. Pharm Res 19:147-153.
44. Gui C, Miao Y, Thompson L, Wahlgren B, Mock M, Stieger B, Hagenbuch B. 2008. Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3. Eur J Pharmacol 584:57-65.
45. Roth M, Timmermann BN, Hagenbuch B. 2011. Interactions of green tea catechins with organic anion-transporting polypeptides. Drug Metab Dispos 39:920-926.
46. Martens K, Ver Loren van Themaat E, van Batenburg MF, Heinaniemi M, Huyghe S, Van Hummelen P, Calrberg C, Van Veldhoven PP, Van Kampen A, Baes M. 2008. Coordinate induction of PPAR alpha and SREBP2 in multifunctional protein 2 deficient mice. Biochim. Biophys. Acta 1781: 694-702.